Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Candidate drugs against SARS-CoV-2 and COVID-19
Dwight L. McKee, Ariane Sternberg, Ulrike Stange, et al.
Pharmacological Research (2020) Vol. 157, pp. 104859-104859
Open Access | Times Cited: 577

Showing 1-25 of 577 citing articles:

Immune response in COVID-19: A review
Mohammad Asaduzzaman Chowdhury, Nayem Hossain, Mohammod Abul Kashem, et al.
Journal of Infection and Public Health (2020) Vol. 13, Iss. 11, pp. 1619-1629
Open Access | Times Cited: 432
Cytokine storm and COVID-19: a chronicle of pro-inflammatory cytokines
Antonella F. Fara, Zan Mitrev, Rodney Alexander Rosalia, et al.
Open Biology (2020) Vol. 10, Iss. 9
Open Access | Times Cited: 328
COVID-19, Mast Cells, Cytokine Storm, Psychological Stress, and Neuroinflammation
Duraisamy Kempuraj, Govindhasamy Pushpavathi Selvakumar, Mohammad Ejaz Ahmed, et al.
The Neuroscientist (2020) Vol. 26, Iss. 5-6, pp. 402-414
Open Access | Times Cited: 266
Novel Coronavirus (COVID-19) and Dentistry–A Comprehensive Review of Literature
Poyan Barabari, Keyvan Moharamzadeh
Dentistry Journal (2020) Vol. 8, Iss. 2, pp. 53-53
Open Access | Times Cited: 223
Structural features of coronavirus SARS-CoV-2 spike protein: Targets for vaccination
Ariane Sternberg, Cord Naujokat
Life Sciences (2020) Vol. 257, pp. 118056-118056
Open Access | Times Cited: 218
In silico ADMET and molecular docking study on searching potential inhibitors from limonoids and triterpenoids for COVID-19
Seshu Vardhan, Suban K. Sahoo
Computers in Biology and Medicine (2020) Vol. 124, pp. 103936-103936
Open Access | Times Cited: 210
Remdesivir and its antiviral activity against COVID-19: A systematic review
Andri Frediansyah, Firzan Nainu, Kuldeep Dhama, et al.
Clinical Epidemiology and Global Health (2020) Vol. 9, pp. 123-127
Open Access | Times Cited: 206
Traditional Chinese medicine in COVID-19
Ming Lyu, Guanwei Fan, Guangxu Xiao, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 11, Iss. 11, pp. 3337-3363
Open Access | Times Cited: 175
Effect of Underlying Comorbidities on the Infection and Severity of COVID-19 in Korea: a Nationwide Case-Control Study
Wonjun Ji, Kyungmin Huh, Minsun Kang, et al.
Journal of Korean Medical Science (2020) Vol. 35, Iss. 25
Open Access | Times Cited: 162
Coronavirus Disease (COVID-19): Current Status and Prospects for Drug and Vaccine Development
Kevin Ita
Archives of Medical Research (2020) Vol. 52, Iss. 1, pp. 15-24
Open Access | Times Cited: 160
Anti-malarial drug, artemisinin and its derivatives for the treatment of respiratory diseases
Dorothy H.J. Cheong, W.S. Daniel Tan, Fred Wong, et al.
Pharmacological Research (2020) Vol. 158, pp. 104901-104901
Open Access | Times Cited: 155
Possible Therapeutic Effects of Adjuvant Quercetin Supplementation Against Early-Stage COVID-19 Infection: A Prospective, Randomized, Controlled, and Open-Label Study
Francesco Di Pierro, Giuseppe Derosa, Pamela Maffioli, et al.
International Journal of General Medicine (2021) Vol. Volume 14, pp. 2359-2366
Open Access | Times Cited: 154
COVID-19: a complex multisystem disorder
Christopher Roberts, Marcel Levi, Martin McKee, et al.
British Journal of Anaesthesia (2020) Vol. 125, Iss. 3, pp. 238-242
Open Access | Times Cited: 145
A compendium answering 150 questions on COVID‐19 and SARS‐CoV‐2
Carmen Riggioni, Pasquale Comberiati, Mattia Giovannini, et al.
Allergy (2020) Vol. 75, Iss. 10, pp. 2503-2541
Open Access | Times Cited: 141
Monocytes and macrophages in COVID-19: Friends and foes
Sepideh Meidaninikjeh, Nasim Sabouni, Hadi Zare Marzouni, et al.
Life Sciences (2021) Vol. 269, pp. 119010-119010
Open Access | Times Cited: 133
Small-Molecule Inhibitors of the Coronavirus Spike: ACE2 Protein–Protein Interaction as Blockers of Viral Attachment and Entry for SARS-CoV-2
Damir Bojadzic, Óscar Garnica, Jinshui Chen, et al.
ACS Infectious Diseases (2021) Vol. 7, Iss. 6, pp. 1519-1534
Open Access | Times Cited: 120
Contributions of human ACE2 and TMPRSS2 in determining host–pathogen interaction of COVID-19
Sabyasachi Senapati, Pratibha Banerjee, Sandilya Bhagavatula, et al.
Journal of Genetics (2021) Vol. 100, Iss. 1
Open Access | Times Cited: 115
Sex‐based differences in severity and mortality in COVID‐19
Mustafa Alwani, Aksam Yassin, Raed M. Al‐Zoubi, et al.
Reviews in Medical Virology (2021) Vol. 31, Iss. 6
Open Access | Times Cited: 112
COVID-19 drugs in aquatic systems: a review
Willis Gwenzi, Rangabhashiyam Selvasembian, Nnanake‐Abasi O. Offiong, et al.
Environmental Chemistry Letters (2022) Vol. 20, Iss. 2, pp. 1275-1294
Open Access | Times Cited: 75
Potential use of polyphenols in the battle against COVID-19
Ines L. Paraiso, Johana S. Revel, Jan F. Stevens
Current Opinion in Food Science (2020) Vol. 32, pp. 149-155
Open Access | Times Cited: 134
Flavonoids: A complementary approach to conventional therapy of COVID-19?
Julia Solnier, Johannes‐Paul Fladerer
Phytochemistry Reviews (2020) Vol. 20, Iss. 4, pp. 773-795
Open Access | Times Cited: 132
COVID-19: A review of the proposed pharmacological treatments
Sarah Lam, Andrew M. Lombardi, Aviv Ouanounou
European Journal of Pharmacology (2020) Vol. 886, pp. 173451-173451
Open Access | Times Cited: 129
Hydroxychloroquine in rheumatic autoimmune disorders and beyond
Eliise Laura Nirk, Fulvio Reggiori, Mario Mauthe
EMBO Molecular Medicine (2020) Vol. 12, Iss. 8
Open Access | Times Cited: 120
Naringenin is a powerful inhibitor of SARS-CoV-2 infection in vitro
Nicola Clementi, Carolina Scagnolari, Antonella D’Amore, et al.
Pharmacological Research (2020) Vol. 163, pp. 105255-105255
Open Access | Times Cited: 115
Curcumin, a traditional spice component, can hold the promise against COVID-19?
Vivek Kumar Soni, Arundhati Mehta, Yashwant Kumar Ratre, et al.
European Journal of Pharmacology (2020) Vol. 886, pp. 173551-173551
Open Access | Times Cited: 113
Page 1 - Next Page

Scroll to top